Amedisys, Inc. Amedisys, Inc.

Amedisys, Inc.

AMED

Pozycja w akcjach #4615
Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of... Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment furnishes a diverse array of services provided within individuals' residences. These services support patients in their recovery from surgeries, chronic ailments, or serious illnesses, and also aim to minimize preventable hospital readmissions. This is achieved through its team of proficient nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, as well as social workers and care assistants who support patients. The Hospice division is dedicated to offering comfort and empathetic support to those facing a terminal illness, encompassing conditions like cancer, heart disease, pulmonary disease, or Alzheimer's. Within the Personal Care segment, patients receive assistance with their routine daily activities. Finally, the High Acuity Care segment extends crucial elements of inpatient hospital care, skilled nursing facility services, and palliative care directly to patients within their own homes. As of December 31, 2021, the company maintained a network comprising 331 home health centers, 175 hospice care centers, 14 personal-care facilities, and 8 high acuity care centers. These facilities are situated across 38 states in the U.S. and the District of Columbia. Amedisys, Inc. was established in 1982 and its principal executive offices are located in Baton Rouge, Louisiana.
Cena akcji
$100.99
Ostatnia synchronizacja: 2025-08-15
Kapitalizacja rynkowa
$3.31B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Amedisys, Inc. (AMED)

Kategoria

Healthcare
Zyski dla Amedisys, Inc. (AMED)
Zyski w Jun 2025 TTM: $149.29M
Według najnowszych raportów finansowych Amedisys, Inc., obecny zysk firmy wynosi $149.29M. W roku 2023 firma osiągnęła zysk w wysokości $39.62M, spadek w porównaniu do zysku z roku 2022, który wynosił $160.24M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Amedisys, Inc. od 2000 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $149.29M 73.16%
2024 $86.22M 117.59%
2023 $39.62M -75.27%
2022 $160.24M -42.82%
2021 $280.23M 32.92%
2020 $210.82M 23.71%
2019 $170.41M 7.18%
2018 $158.99M 96.76%
2017 $80.80M 31.24%
2016 $61.57M -20,088.96%
2015 $-308.00K -101.47%
2014 $20.98M -113.67%
2013 $-153.48M 29.30%
2012 $-118.70M -75.21%
2011 $-478.80M -358.00%
2010 $185.58M -16.55%
2009 $222.39M 57.33%
2008 $141.36M 36.68%
2007 $103.42M 67.08%
2006 $61.90M 26.99%
2005 $48.74M 46.11%
2004 $33.36M 144.80%
2003 $13.63M -637.98%
2002 $-2.53M -147.83%
2001 $5.30M -405.60%
2000 $-1.73M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$9.87B 6,511.96%
US
- -
DE
$3.87B 2,488.92%
US
$687.82M 360.73%
SA
$1.25B 735.10%
BR